Adicet Bio, Inc. (ACET) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Adicet Bio reported revenue of $0. Net income was -$116.8M, or -$16.95 per diluted share. Operating activities generated -$95.2M of cash, leaving -$97.0M of free cash flow. At fiscal year end, Adicet Bio held $192.4M in total assets against $33.1M in total liabilities, including $38.9M of cash and equivalents.
Open the full interactive Adicet Bio financials → Quarterly statements, key ratios, valuation history and price charts.
Adicet Bio Key Stats
| Share Price | $5.11 |
|---|---|
| Market Cap | $54.9M |
| 52-Week Range | $5.11 – $16.64 |
| Shares Outstanding | 10.7 million (basic, 2026 Q2) |
Adicet Bio Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$39.2M | -$61.4M | -$72.6M | -$152.0M | -$127.6M | -$122.1M |
| Pre-Tax Income | -$39.5M | -$62.1M | -$69.8M | -$142.7M | -$117.1M | -$116.8M |
| Income Tax | -$2.8M | -$125,000 | $0 | $0 | $0 | $0 |
| Net Income | -$36.7M | -$62.0M | -$69.8M | -$142.7M | -$117.1M | -$116.8M |
| Diluted EPS | -$80.16 | -$32.00 | -$27.20 | -$52.96 | -$21.28 | -$16.95 |
Adicet Bio Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$26.9M | -$30.5M | -$20.2M | -$21.4M |
| Diluted EPS | -$4.64 | -$4.43 | -$1.88 | -$1.99 |
Adicet Bio Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $84.3M | $277.5M | $257.7M | $159.7M | $56.5M | $38.9M |
| Current Assets | $100.3M | $282.4M | $261.0M | $162.3M | $180.1M | $160.9M |
| Total Assets | $153.8M | $338.9M | $330.7M | $207.3M | $220.2M | $192.4M |
| Current Liabilities | $22.5M | $16.3M | $19.7M | $19.3M | $19.4M | $21.5M |
| Total Liabilities | $44.0M | $35.8M | $38.4M | $37.1M | $33.6M | $33.1M |
| Shareholders' Equity | $109.8M | $303.1M | $292.3M | $170.2M | $186.6M | $159.2M |
Adicet Bio Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$41.6M | -$51.1M | -$44.8M | -$93.7M | -$92.4M | -$95.2M |
| Cash From Investing | $115.2M | -$2.8M | -$16.8M | -$4.5M | -$119.2M | $2.4M |
| Cash From Financing | $303,000 | $242.7M | $41.5M | $236,000 | $111.3M | $75.2M |
| Free Cash Flow | -$42.5M | -$64.1M | -$61.5M | -$98.2M | -$93.5M | -$97.0M |
Figures from Adicet Bio's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Adicet Bio financials page for every line item.
Adicet Bio Company Profile
| Ticker | ACET |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Boston, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 26 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001720580 |
Frequently Asked Questions
What was Adicet Bio's revenue in fiscal 2025?
Adicet Bio (ACET) reported revenue of $0 for fiscal 2025.
What is Adicet Bio's annual revenue history?
Adicet Bio's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Adicet Bio's net income in fiscal 2025?
Adicet Bio reported net income of -$116.8M for fiscal 2025.
What was Adicet Bio's earnings per share (EPS) in fiscal 2025?
Adicet Bio's diluted EPS was -$16.95 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Adicet Bio generate in fiscal 2025?
Adicet Bio generated -$97.0M of free cash flow in fiscal 2025.
What was Adicet Bio's revenue last quarter?
In its most recent reported quarter (2026 Q2), Adicet Bio reported revenue of $0.
How many shares of Adicet Bio are outstanding?
Adicet Bio reported a weighted average of 10.7 million basic shares outstanding in 2026 Q2.
What is Adicet Bio's market cap?
Based on its latest closing price, Adicet Bio (ACET) has a market capitalization of about $54.9M.
When does Adicet Bio's fiscal year end?
Adicet Bio's fiscal year end, as registered with the SEC, is December 26.
Where is Adicet Bio headquartered?
Adicet Bio lists its business address in Boston, Massachusetts in its SEC filings.